Ray Dalio Astrazeneca PLC Transaction History

Bridgewater Associates, LP

$19.6 Billion
Q1 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Astrazeneca PLC stock. As of the latest transaction made, Bridgewater Associates, LP holds 99,262 shares of AZN stock, worth $7.74 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

99,262

Previous 160,050 37.98%

Holding current value

$7.74 Million

Previous $10.8 Million 37.61%

% of portfolio

0.03%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $3.71 Million - $4.23 Million	-60,788 Reduced 37.98%	99,262 $6.73 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $2.86 Million - $3.2 Million	46,241 Added 40.63%	160,050 $10.8 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $262,512 - $290,241	4,048 Added 3.69%	113,809 $7.71 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $849,336 - $921,015	12,149 Added 12.45%	109,761 $7.86 Million
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $504,821 - $572,370	7,994 Added 8.92%	97,612 $6.78 Million

Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $532,721 - $692,213	9,827 Added 12.32%	89,618 $6.08 Million
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $465,992 - $1.19 Million	8,789 Added 12.38%	79,791 $4.38 Million
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $330,907 - $397,245	-5,584 Reduced 7.29%	71,002 $4.69 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $205,829 - $247,941	3,694 Added 5.07%	76,586 $5.08 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $1.69 Million - $2 Million	-31,341 Reduced 30.07%	72,892 $4.25 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $716,557 - $784,008	12,897 Added 14.12%	104,233 $6.26 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $4.42 Million - $5.5 Million	91,336 New	91,336 $5.47 Million

Others Institutions Holding AZN

# of Institutions

1,244

Shares Held

477M

Call Options Held

5.99M

Put Options Held

5.24M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $242B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account